residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer
Published 4 years ago • 1.2K plays • Length 10:28Download video MP4
Download video MP3
Similar videos
-
7:22
residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer
-
20:11
residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer
-
2:53
managing residual disease after neoadjuvant therapy in breast cancer
-
1:45
association of pathologic complete response following neoadjuvant chemotherapy with longterm sur...
-
36:42
evaluation of breast specimens after neoadjuvant chemotherapy
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
8:55
survival outcomes from the calgb 40603 study in triple-negative breast cancer
-
2:43
mbcc 2017: residual cancer burden may be better outcome measure than pcr
-
2:25
reducing risk in residual breast cancer
-
5:47
the meaning of residual disease in breast cancer
-
6:12
patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast mr imaging
-
8:22
the immune landscape of residual tnbc after neoadjuvant chemotherapy
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
2:52
neoadjuvant and adjuvant therapy in triple negative breast cancer
-
4:32
residual cancer burden in tnbc patients receiving neoadjuvant chemotherapy
-
27:18
adjuvant and neoadjuvant dilemmas
-
1:10
dr. tereffe on treatment after neoadjuvant chemotherapy in breast cancer
-
3:18
escalation and descalation in neoadjuvant time to treatment of tnbc
-
1:16
tackling residual disease in breast cancer